Pfizer Inc Archives - HealthQuill

The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in people 18-59 years.

US drug regulator FDA approves expanded use of Pfizer’s RSV vaccine

The US Food and Drug Administration has greenlighted Pfizer Inc.’s respiratory syncytial virus vaccine (RSV) Abrysvo for treating lower respiratory tract disease in.

by HealthQuill
October 23, 2024
0 Comments

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder in haemophilia patients.

Drugs Health Pharma

Pfizer’s drug to treat rare haemophilia disorder gets US regulator’s approval

Pfizer Inc., got a nod from the US drug regulator for its drug Hympavzi to treat two types of a rare blood disorder.

by HealthQuill
October 13, 2024
0 Comments

Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a company statement.

Drugs Health Pharma

Pfizer pulls out sickle cell therapy from global markets, cites death, snags

Pfizer Inc.’s sickle cell therapy involving Oxbryta has been voluntarily withdrawn from global markets due to painful complications and death, according to a.

by HealthQuill
September 26, 2024
0 Comments

The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which incorporates a new component to fight a variant of the virus.

Drugs Health Pharma

FDA approves new Covid-19 jabs before fall and winter in the United States

The US Food and Drug Administration has granted emergency use authorisation to the Covid-19 vaccine made by Pfizer Inc., and ModernaTX Inc., which.

by HealthQuill
August 23, 2024
0 Comments

Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine would maintain protection from the disease through to a second season.

Drugs Health Pharma

Pfizer says RSV vaccine can ensure protection into second season

HQ Team March 1, 2024: Pfizer Inc., a US pharmaceutical and biotechnology corporation, announced its single dose of respiratory syncytial virus (RSV) vaccine.

by HealthQuill
March 1, 2024
0 Comments

Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring its business and management.

Drugs Health Pharma

Pfizer revamps organisation as $43 billion Seagen deal comes to close

HQ Team December 13, 2023: Pfizer is expected to close the $43 billion acquisition of Seagen by Thursday as the company announced restructuring.

by HealthQuill
December 13, 2023
0 Comments

Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50% of the patients opted out due to adverse effects of the medicine.

Drugs Health Pharma

Pfizer Inc., stops twice-daily oral obesity drug trial at mid-stage

HQ Team December 2, 2023: Pfizer Inc., has discontinued its clinical trials of the twice-daily oral weight-loss drug, danuglipron, after more than 50%.

by HealthQuill
December 2, 2023
0 Comments

An advisory panel of the national public agency of the US, Centers for Disease Control and Prevention, has provisionally recommended Pfizer’s vaccine for respiratory syncytial virus in pregnant women to protect infants during the infection season.

Drugs Health Pharma

CDC panel backs Pfizer’s respiratory virus vaccine to protect infants

HQ Team September 23, 2023: An advisory panel of the national public agency of the US, Centers for Disease Control and Prevention, has.

by HealthQuill
September 23, 2023
1 Comment

The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss or alopecia aerate.

Drugs Health Pharma

Pfizer’s oral capsule Litfulo to treat hair loss gets EU approval

HQ Team September 19, 2023: The European Commission granted Pfizer Inc., a marketing authorisation for its once-daily oral capsule to treat hair loss.